Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies

Por Burger, Robert A.
Publicado em 2010

Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an...

Por Duska, Linda R., Java, James J., Cohn, David E., Burger, Robert A.
Publicado no Gynecol Oncol (2015)

Cytokine Use And Survival In The First-Line Treatment Of Ovarian Cancer: A Gynecologic Oncology Group Study

Por Stehman, Frederick B., Brady, Mark F, Thigpen, J Tate, Rossi, Emma C., Burger, Robert A.
Publicado em 2012

Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology G...

Por Randall, Leslie M., Sill, Michael W., Burger, Robert A., Monk, Bradley J., Buening, Barbara, Sorosky, Joel I.
Publicado em 2011

Neurotoxicity in Ovarian Cancer Patients on Gynecologic Oncology Group (GOG) Protocol 218: Characteristics Associated with Toxicity and the Effect of Substitution with Docetaxel: A...

Por Chase, Dana M., Huang, Helen, Foss, Cassandra D., Wenzel, Lari B., Monk, Bradley J., Burger, Robert A.
Publicado no Gynecol Oncol (2014)

Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Por Monk, Bradley J., Sill, Michael W., Burger, Robert A., Gray, Heidi J., Buekers, Thomas E., Roman, Lynda D.
Publicado em 2009

Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary perito...

Por Burger, Robert. A., Brady, Mark F., Rhee, Joon, Sovak, Mika A., Kong, George, Nguyen, Hoa P., Bookman, Michael A.
Publicado em 2013

PROSPECTIVE EVALUATION OF AN IN VITRO RADIATION RESISTANCE ASSAY IN LOCALLY ADVANCED CANCER OF THE UTERINE CERVIX: A SOUTHWEST ONCOLOGY GROUP STUDY

Por Randall, Leslie M, Monk, Bradley J, Moon, James, Parker, Ricardo, Al-Ghazi, Muthana, Wilczynski, Sharon, Fruehauf, John P, Markman, Maurie, Burger, Robert A
Publicado em 2010

A cost-utility analysis of an NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected Quality-of-life scores in an economic model of treatment o...

Por Cohn, David E, Barnett, Jason C, Wenzel, Lari, Monk, Bradley J, Burger, Robert A, Straughn, J Michael, Myers, Evan R, Havrilesky, Laura J
Publicado no Gynecol Oncol (2014)

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

Por Randall, Leslie M., Monk, Bradley J., Darcy, Kathleen M., Tian, Chunqiao, Burger, Robert A., Liao, Shu-Yuan, Peters, William A., Stock, Richard J., Fruehauf, John P.
Publicado em 2008

Patient Reported Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: A Gynecologic Oncology Group Study

Por Monk, Bradley J., Huang, Helen Q., Burger, Robert A., Mannel, Robert S., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Liang, Sharon X., Wenzel, Lari
Publicado em 2012

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer

Por Welsh, John B., Zarrinkar, Patrick P., Sapinoso, Lisa M., Kern, Suzanne G., Behling, Cynthia A., Monk, Bradley J., Lockhart, David J., Burger, Robert A., Hampton, Garret M.
Publicado em 2001

Prognostic Relevance of Carbonic Anhydrase-IX in High-Risk, Early-Stage Cervical Cancer: A Gynecologic Oncology Group Study

Por Liao, Shu-Yuan, Darcy, Kathleen M., Randall, Leslie M., Tian, Chunqiao, Monk, Bradley J., Burger, Robert A., Fruehauf, John P., Peters, William A., Stock, Richard J., Stanbridge, Eric J.
Publicado em 2009

PREDICTIVE AND PROGNOSTIC ANGIOGENIC MARKERS IN A GYNECOLOGIC ONCOLOGY GROUP PHASE II TRIAL OF BEVACIZUMAB IN RECURRENT AND PERSISTENT OVARIAN OR PERITONEAL CANCER

Por Han, Ernest S., Burger, Robert A., Darcy, Kathleen M., Sill, Michael W., Randall, Leslie M., Chase, Dana, Parmakhtiar, Basmina, Monk, Bradley J., Greer, Benjamin E., DeGeest, Koen, Fruehauf, John P.
Publicado em 2010

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Por Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Publicado no Gynecol Oncol (2015)

VEGF is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary

Por Mabuchi, Seiji, Kawase, Chiaki, Altomare, Deborah A., Morishige, Kenichirou, Hayashi, Masami, Sawada, Kenjiro, Ito, Kimihiko, Terai, Yoshito, Nishio, Yukihiro, Klein-Szanto, Andres J., Burger, Robert A., Ohmichi, Masahide, Testa, Joseph R., Kimura, Tadashi
Publicado em 2010

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

Por Burger, Robert A., Brady, Mark F., Bookman, Michael A., Monk, Bradley J., Walker, Joan L., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Fleming, Gini F., Lim, Peter C., Rubin, Stephen C., Katsumata, Noriyuki, Liang, Sharon X.
Publicado em 2014

American Society of Clinical Oncology Position Statement on Obesity and Cancer

Por Ligibel, Jennifer A., Alfano, Catherine M., Courneya, Kerry S., Demark-Wahnefried, Wendy, Burger, Robert A., Chlebowski, Rowan T., Fabian, Carol J., Gucalp, Ayca, Hershman, Dawn L., Hudson, Melissa M., Jones, Lee W., Kakarala, Madhuri, Ness, Kirsten K., Merrill, Janette K., Wollins, Dana S., Hudis, Clifford A.
Publicado no J Clin Oncol (2014)

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

Por Bookman, Michael A., Brady, Mark F., McGuire, William P., Harper, Peter G., Alberts, David S., Friedlander, Michael, Colombo, Nicoletta, Fowler, Jeffrey M., Argenta, Peter A., De Geest, Koen, Mutch, David G., Burger, Robert A., Swart, Ann Marie, Trimble, Edward L., Accario-Winslow, Chrisann, Roth, Lawrence M.
Publicado em 2009

Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer

Por Esselen, Katharine M., Cronin, Angel M., Bixel, Kristin, Bookman, Michael A., Burger, Robert A., Cohn, David E., Cristea, Mihaela, Griggs, Jennifer J., Levenback, Charles F., Mantia-Smaldone, Gina, Meyer, Larissa A., Matulonis, Ursula A., Niland, Joyce C., Sun, Charlotte, O’Malley, David M., Wright, Alexi A.
Publicado no JAMA Oncol (2016)